Trial Profile
Additive effect of elcatonin with risedronic acid in patients with osteoporosis associated with chronic back pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary) ; Elcatonin
- Indications Back pain; Osteoporosis
- Focus Adverse reactions; Therapeutic Use
- 20 May 2016 New trial record